CFR section
21 CFR 530.20(a)(1): Conditions for permitted extralabel animal and human drug use in food-producing animals
PART 530-EXTRALABEL DRUG USE IN ANIMALS · Subpart C-Specific Provisions Relating to Extralabel Use of Animal and Human Drugs in Food-Producing Animals
Key facts
| Citation | 21 CFR 530.20(a)(1) |
|---|---|
| Section | Conditions for permitted extralabel animal and human drug use in food-producing animals |
| Part | PART 530-EXTRALABEL DRUG USE IN ANIMALS |
| Subpart | Subpart C-Specific Provisions Relating to Extralabel Use of Animal and Human Drugs in Food-Producing Animals |
| Subchapter | 21 CFR E Drugs Animal |
| Product types cited | Veterinary |
| Regulation text (excerpt) | (1) There is no approved new animal drug that is labeled for such use and that contains the same active ingredient which is in the required dosage form and concentration, except where a veterinarian finds, within the context of a valid veterinarian-client-patient relationship, that the approved new animal drug is clinically ineffective for its intended use. |
At a glance
- 10–99 Inspections citing this section
- 1–9 Warning letters citing this section
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About CFR sections cited by the FDA
Title 21 of the Code of Federal Regulations contains the FDA's regulations, including current good manufacturing practice and quality system requirements that inspections cite.